Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device

News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Boston Sci: investment grade

You may also be interested in...



FDA Panel Unanimously Supports Berlin Heart's Excor Pediatric VAD

Following strong support from an FDA advisory panel, Berlin Heart is hoping for humanitarian device approval of its Excor Pediatric ventricular assist device within the next six months.

FDA Panel Unanimously Supports Berlin Heart's Excor Pediatric VAD

Following strong support from an FDA advisory panel, Berlin Heart is hoping for humanitarian device approval of its Excor Pediatric ventricular assist device within the next six months.

News In Brief

Kensey Nash picks up Norian

Table

View full table

Topics

Tags:
Medical Device
Latest Headlines

News We’re Watching – LivaNova And Medtronic Recalls; Approvals For Abbott And Guardant; Pediatric Device Grants

Legal Expert Weighs In On New US Mandate To Diversify Clinical Trials

Global Medtech Guidance Tracker: January 2023

UK Medtech Strategy Promises To Use Innovation Effectively And Build Resilience

See All
UsernamePublicRestriction

Register

MT030373

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By